Pfizer Whistleblower Raises Serious Questions on Clinical Trial Data Integrity & Regulatory Oversight
BMJ article: “In autumn 2020 Pfizer’s chairman and chief executive, Albert Bourla, released an open letter to the billions of people around the world who were investing their hopes in a safe …
